A novel endothelial-specific membrane protein is a marker of cell-cell contacts by unknown
A Novel Endothelial-specific Membrane Protein 
Is a Marker of Call-Cell Contacts 
M. G. Lampugnani,* M. Resnati,* M. Raiteri,* R. Pigott,~ A. Pisacane,* G. Houen, II, L. P. Ruco,* 
and E. Dejana* 
*Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy; *Dipartimento di Biopatologia Umana, 
Universit~ di Roma'La Sapienza', 00161 Roma, Italy; w  British Bio-technology Ltd, Watlington Rd, Cowley Oxford OX45LY, UK; and 
II Institut for Biokemisk Genetik, K$benhavns Universitet, 1353 KCbenhavn, Denmark 
Abstract.  mAbs were raised in mice against cultured 
human endothelial cells (EC) and screened by indirect 
immunofluorescence for their ability to stain intercel- 
lular contacts.  One mAb denoted 7B4 was identified 
which,  out of many cultured cell types, specifically 
decorated cultured human EC.  The antigen recognized 
by mAb 7B4 is bound at the appositional surfaces of 
cultured EC only as they become confluent and is sta- 
bly expressed at intercellular boundaries of confluent 
monolayers.  EC recognition specificity was maintained 
when the antibody was assayed by immuno- 
histochemistry  in tissue sections of many normal and 
malignant tissues and in blood vessels of different size 
and type. The antigen recognized by 7B4 was enriched 
at EC intercellular boundaries similarly  in vitro and in 
situ.  In vitro, addition of mAb 7B4 to confluent EC 
increased permeation of macromolecules across 
monolayers even without any obvious changes of cell 
morphology.  In addition,  when EC permeability was 
increased by agents such as thrombin,  elastase,  and 
TNF/~/IFN,  its distribution pattern at intercellular con- 
tact rims was severely altered,  mAb 7B4 immunopre- 
cipitated a major protein of 140 kD from metaboli- 
caUy and surface-labeled cultured EC extracts which 
appeared to be an integral membrane glycoprotein. On 
the basis of its distribution in cultured cells and in tis- 
sues in situ, 7B4 antigen is distinct from other de- 
scribed EC proteins enriched at intercellular contacts. 
NH2-terminal sequencing of the antigen,  im- 
munopurified from human placenta,  and sequencing of 
peptides from tryptic peptide maps revealed identity to 
the cDNA deduced sequence of a recently identified 
new member of the cadherin family (Suzuki,  S., K. 
Sano, and H. Tanihara.  1991.  Cell Regul. 2:261-270.) 
These data indicate that 7134 antigen is an endothelial- 
specific cadherin that plays a  role in the organization 
of lateral endothelial junctions and in the control of 
permeability properties of vascular endothelium. 
T 
HE structural  and functional  integrity  of the endothe- 
lium  is  an essential  requirement for its property of 
permselective barrier between the blood stream and 
the underlying tissues. The maintenance  of a continuous en- 
dothelial  cell (EC) t monolayer of tightly  apposed cells is 
also central for preventing the vessel wall from platelet depo- 
sition  and  thrombus  formation.  Morphological  studies  in 
vitro and in vivo have shown the presence of tight junctions 
and gap junctions between adjacent EC.  (Schneeberger and 
Lynch,  1984; Franke et al.,  1988). 
In other cell types, cell-cell adhesion structures have been 
extensively studied and specific molecules of both the cal- 
cium dependent and independent  cell adhesion mechanisms 
have been identified  (Cunningham,  1990; Takeichi,  1990) 
but, in spite of the importance of cell-cell junctions in the 
maintenance of the endothelial  functional properties, little is 
known about their structural and molecular organization. 
1. Abbreviation used in this paper:  EC, endothelial cell. 
So far, a few integral  membrane proteins have been de- 
scribed in the EC intercellular  domain: PECAM-1 (Newman 
et al.,  1990),  also called  CD31  (Simmons  et  al.,  1990; 
Miiller  et al.,  1989) or endo-CAM (Albelda et al.,  1990); 
V-cadherin in bovine EC (Heimark et al., 1990) and the inte- 
grins  ct~/3~ and  o~2/3~ (Lampugnani  et  al.,  1991). Among 
these proteins,  however, only V-cadherin was expressed ex- 
clusively in EC from bovine vessels. PECAM-1 was detected 
also in monocytes, polymorphonuclear cells,  and platelets 
while ots/3t and  o~2/3~ integrins  have a widespread distribu- 
tion. While the distribution and localization of the above pro- 
teins are well described, their role in the maintenance  of EC 
intercellular  contacts is not yet clear.  Recently,  PECAM-1 
has been shown to mediate cell-cell adhesion of full-length 
PECAM-1 cDNA transfected  cell (Albelda et al.,  1991). 
To characterize the structures involved in EC intercellular 
junctions we raised mouse mAbs against  cultured human 
umbilical vein EC.  The resulting  antibodies were screened 
by indirect  immunofluorescence  for their ability to stain in- 
tercellular boundaries of cultured human EC in monolayer. 
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tained that recognized an apparently  novel antigen  that was 
strictly distributed at intercellular EC boundaries not only in 
vitro  but  also  in  endothelia  lining  intact  vessels  within 
tissues. 
Materials and Methods 
Antibodies 
n'tAbs to cultured human EC from umbilical vein were raised in mice as 
extensively described by Pigott et al.,  1991. The isotype of both 7IM and 
9GI 1 mAbs was IGgl. Purified antibodies were prepared from hybridoma 
supernatants by affinity chromatography on Prosep-A (Bioprocessing  Ltd., 
Consett,  England).  Fab  fragments  were  obtained  by  papain  digestion 
(Pierce Chemical Co., Rockford,  IL). mAb 9GI I  recognizes the antigen 
PECAM-1/CD31  (Simmons et al., 1990). As negative control either ascitic 
fluid containing the isotype  matched mAb to CD2  lymphocyte antigen 
(OKTll,  Ortho Diagnostic System Inc., Raritan, N.J.),  which is not ex- 
pressed by EC, or purified nonimmune mouse IgG (Calbiochem, La Jolla, 
CA) were used as indicated. 
Rabbit  anti-pan-cadherin serum  (Geiger  et  al.,  1990)  was  kindly 
provided by Dr.  B. Geiger (Weizmann Institute, Israel). Rabbit serum to 
N- or P-cadherin were a kind gift of Dr.  Vestweber (MPI fOr Immunobi- 
ologie, Freiburg, Germany). These t~  antibodies were raised against bac- 
terial fusion proteins containing, respectively, the human P-cadherin coding 
sequence from bp 759 to the natural stop codon and the mouse N-cadherin 
coding sequence from bp 1755 to 3 amino acids before the natural stop. 
mAb (Ec6C10) and rabbit polyclonal (6422) antibodies to V-cadherin were 
kindly provided by Dr. R. L. Heimark (ICOS Corporation, Bothell, WA), 
Cells 
Human EC were isolated from umbilical vein (Barbieri et al.,  1981) by 
treatment with collagenase  (0.1% from Clostridium histolyticum, Boeh- 
ringer Mannheim, Germany) for 20 rain at 37~  Cells were cultured in 
medium 199 (Gibco Laboratories, Grand Island, NY) with 20% newborn 
calf serum (NCS; Gibco Laboratories). 100 #g/ml endothelial cell growth 
supplement (ECGS, prepared from bovine brain), 100 #g/ml heparin (from 
porcine intestinal mucosa; Sigma Chemical Co., St. Louis, MO, USA), 50 
U/ml penicillin, 50 #g/ml streptomycin,  2.5 #g/rnl fungizone at 37~  Cells 
up to 10 in vitro passages were used. 
Human femoral artery smooth muscle cells were a kind girl of Dr. G. 
Gabbiani (Department of Pathology,  University of Geneva, Geneva, Swit- 
zerland) and cultured in DME (Gibco Laboratories) with 10% fetal calf se- 
rum (Gibco Laboratories). Human epidermal keratinocytes were kindly 
provided by Dr. M. De Luca (IST, Genova, Italy) and cultured as described 
by Marchisio et al. (1991). 
Human dermal fibroblasts were cultured in medium 199 with 20% NCS. 
Human blood polymorphonuclear cells (PMN) (Bazzoni  et al.,  1991), 
platelets (Del Maschio et al.,  1990) and monocytes (Colotta et al.,  I984) 
were isolated and washed as previously described in the related references. 
Cell Treatments 
Purified human c~-thrombin (1,665 U/mg) kindly donated by Dr. J. W. Fen- 
ton II (State University of New York at Albany) and human etastase (875 
U/rag; from human sputum, ECP, Elastin Products,  Owensville,  MO) were 
used.  They were added in serum free culture medium to confluent EC at 
the  indicated doses  and time intervals.  Treatment with tumor  necrosis 
factor-a (TNF,  100 U/ml human recombinant, Basf-Knoll,  Germany) and 
￿9  y-interferon (human recombinant ~/IFN, 200 U/ml, Hoffman  La Roche, 
Nufley, NI) was started 24 h after cell seeding and continued for 72-96 h. 
When 7B4 either intact IGgs or Fab fragments were used in permeability 
experiments they were added in medium 199 with 5% NCS. 5 mM EGTA 
in serum-free culture medium was used to decrease extracellular Ca  2+ con- 
centration (Heimark et al., 1990) in permeability and immunofluorescence 
experiments for the time intervals indicated.  Neuraminidase (2 U/ml, from 
Clostridium perfringens,  type  X;  Sigma Chemical  Co.)  was  added  to 
confluent 12Slodine surface-labeled EC  (see  below),  in Ca  2+ and Mg  2+ 
PBS, pH 5.3, for 45 rain at 37"C before cell processing for immunoprecipi- 
ration as described below. Treatment of ~2~Iodine-labeled EC with trypsin 
(0.01%, Sigma "Pype  III, 13,900 u/mg) was in Ca-Mg free Hanks buffer with 
either  1 rnM Ca  2+ or  1 mM  EGTA for 20 min at 37~  Trypsin was 
stopped with soybean trypsin inhibitor (0.05 % Sigma,  1 nag inhibiting 1.6 
nag trypsin with 10,000 U/rag) before cell processing for immunoprecipita- 
tion. Control incubations were in Hanks with 1 mM EGTA or 1 mM Ca  2+ 
and I mM Mg  2+. Phosphatidylinositol (PI)-specific phospholipaseC (PLC, 
2 #g/ml Boehringer Mannheim) (Plong et at.,  1991) in serum-free culture 
medium was given to 125Iodine-labeled EC for 20 min at 37~  before cell 
extraction for immunoprecipitation. Treatment with EDTA (50 #M) after 
12Slodine surface labeling of conflnent EC was for 15 min at 37~  (M~ller 
et al.,  1989).  Cells were then processed for immtmoprecipitation as de- 
scribed below. 
Cell Labeling and Extraction 
[35S]Methionine Metabolic Labeling. EC which had grown to conflnency, 
unless  otherwise indicated,  on gelatin-coated  10-cm:  well  plates  were 
washed  twice with methionine-free RPMI (Gibeo Laboratories) and cul- 
tured overnight in methionine-free RPMI with 20% NCS ECGS, and hepa- 
rin (see above) comaining 60 #Cilml [3~S]methionine (Amersham Interna- 
tional, Buckingham, UK).  Cell layers were then washed three times with 
serum-free medium 199 and extracted with 280 ttl of 10 mM NaCI,  10 mM 
Tris-HCl, 0.5 % sodium deoxycholate,  1% Tween 40, 1 mM PMSE 20 U/ml 
aprotinin, pH 7.4. Cell extracts were centrifuged for 5 rain in an Eppendorf 
centrifuge at 13,000 rpm. The supernatant was stored at -20~  for immu- 
noprecipitation analysis. 
~25Iodine-Surface Labeling. EC which had grown to confluency, unless 
otherwise indicated, on gelatin-coated 10 cm  2 well  plates were  washed 
three times with Ca2+-Mg  2+ Dulbecco's  PBS. Cells were labeled using the 
glucose oxidase-laetoperoxidase method (Labien et al., 1982). Briefly, one 
well was incubated with 500 tzl Ca2+-Mg  2+ PBS containing 20 #g/ml lac- 
toperoxidase,  0.25  U/ml glucose oxidase,  200 tzCi/ml  125Iodine (NEN, 
DuPont, Dreieichenhain, Germany). 2.5 mM glucose for 5 min on ice. Glu- 
cose, 2.5 mM, was added again and the reaction continued for 5 more min. 
The reaction was stopped with 3 ml of  medium 199 containing 0.02 % azide. 
The cell layer was washed three more times with medium 199 containing 
0.02 % azide and extracted as described above. In a few experiments,  cell 
extraction was with 150 mM NaC1, 10 mM Tris HCI, 1 mM PMSF, 20 U/ml 
aprotinin, and either 1% Triton X-100 (TX-100) or 1% Triton X-II4 (TX- 
114). TX-114 buffer and detergent phase were separated as described by 
Bordier (1981). 
lmmunoprecipitation 
Protein G-Sepbarose (recombinant; Pharmacia,  Uppsala,  Sweden) was 
washed three times with TBS (150 mM NaC1, 10 mM Tris-HCl, pH 7.4). 
For each sample,  the resin pelleted from 500 t~l of a  10% suspension was 
used. Coupling with the antibodies (either 500 #1 undiluted hybridoma con- 
ditioned medium for 7134 and 9GII or 25/~g/ml of purified IgGs or 300 
#1 TBS containing a 1:200 dilution of the nonrelevant IgG isotype matched 
CD2 ascitic fluid) was for 60 rain at room temperature under continuous 
mixing. The resin was then washed with TBS containing 1% Tween 40,  1 
mM PMSF,  20 U/ml aprotinin, and 1 mM CaCI2, MgC12, and MnCI2, 
respectively  (immunoprecipitation buffer).  Incubation of cell extracts with 
protein G-Sepharose was in a total volume of 300-500 #I immunoprecipita- 
tion buffer for 1 h at room temperature under continuous mixing. The pres- 
ence of divalent cations during this phase was mandatory to effective immu- 
noprecipitation with mAb 7B4. In some experiments,  as indicated, samples 
were precleared by incubating them for 1 h with uncoupled protein G-Seph- 
arose. The supernatant was collected and used in immunoprecipitation. The 
resin was washed three times with immunoprecipitation  buffer (1 ml a time). 
Sample buffer 2￿  (50/~1 of 20% Tris-HCl 0.5 M, pH 6.8, 5% SDS, 20% 
glycerol, 0.25 mg/ml bromophenol in water; when indicated 5 % 2-mercap- 
toethanol was added as a reducing agent) was added to the resin pellet which 
was boiled for 3 min. Supernatant was analyzed by electrophoresis on a 
7.5% polyacrylamide gel in the presence of SDS. In each separation, 14C- 
molecular weight standard proteins (Amersham International) were run in 
parallel to the samples.  Dryed gels were exposed  for autoradiography  on 
X-AR  film  (Eastman Kodak  Co.,  Rochester,  NY)  at  -70"C.  Gels with 
[3SS]methionine  labeled  samples  were  equilibrated  with  EN3HANCE 
(NEN) before drying and exposure.  Quantification of the band was made 
after digital image analysis of the film (RAS 3000 Loats System; Amersham 
International). 
Lectin Binding 
Cell  extracts  from  ~25Iodine-labeled EC  were  incubated  with  Con  A 
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1 mM MnC12 (binding buffer) either in the absence or in the presence of 
0.5 M methyl c~-o marmopyranoside (Sigma Chemical Co.) for 1 h at room 
temperature. The unbound fraction (supernatant) was stored. The resin was 
washed with binding buffer and bound material (eluant) eluted, incubating 
the resin with the competing sugar methyl-cc-D mannopyranoside (0.5 M) 
for 1 h at room temperature. Both the supernatant and the eluant fractions 
were subjected to immunoprecipitation. Binding to wheat germ agglutinin 
(WGA) agarose (Pharmacia) was identical to the binding to Con A except 
that N-acetyl-D-glucosamine (0.5  M;  Sigma Chemical Co.) was used as 
competing sugar. 
Immunoblotting 
After separation by SDS-electrophoresis, samples were electrotransferred 
onto nitrocellulose (Bio-Rad Laboratories, Richmond, CA) blocked with 
3 % BSA (fatty acid free type; Sigma Chemical Co.) in PBS and incubated 
overnight with a  1:100 dilution of either a rabbit anti-pan-cadherin serum 
or rabbit serum to N- or P-cadherin (see previous "Antibodies" section). 
The immunoreactive bands were revealed by 125Iodine-labeled protein A 
(Amersham International) followed by autoradiography. 
Immunofluorescence 
Cells to be examined by immunofluorescence microscopy were grown on 
glass coverslips. Glass coverslips (13-ram diameter) were coated overnight 
at 4~  with either 1.5% gelatin (Difco) or 7 #g/ml fibronectin purified from 
human plasma (Engvall and Ruoslahti, 1977) or 7 #g/ml vitronectin purified 
from human serum (Yatohgo  et al.,  1988),  then rinsed with serum-free 
medium  199  before seeding 3.5  x  104 cells/coverslip in 0.4  ml culture 
medium.  Cells  were  grown  to  confluency  for  72  h,  unless  otherwise 
specified. Coverslip-attached cells were then fixed with paraformaldehyde 
and processed for immunofluorescence  microscopy as previously described 
in detail  (Lampugnani et al.,  1991). Briefly,  the primary antibody was 
layered on fixed and permeabilized cells and incubated in a humid chamber 
for 30 min. After rinsing in 0.1% BSA in TBS, coverslips were incubated 
in the appropriate rhodamine-tagged second antibody (Dakopatts, Glostrup, 
Denmark) for 30 min at 37~  in the presence of 0.2 #g/ml of fluorescein- 
labeled phalloidin (F-PHD; Sigma Chemical Co.).  Coverslips were then 
mounted in Mowiol 4-88 (Hoechst, Frankfurt, Germany). 
Observations were carried out in a  Zeiss Axiophot photomicroscope 
equipped for epifluorescence. Fluorescence images were recorded on Ko- 
dak T-Max 400 films exposed at 1000 ISO and developed in Kodak T-Max 
developer for 10 rain at 20~ 
Immunohistochemistry 
Fragments of human normal kidney (2), heart (2),  lung (3),  thymus (3), 
lymph nodes (5), thyroid (2), parathyroid (1), salivary gland (1), stomach 
(2), small and large intestine (2), testis (1), bone marrow (1), placenta (1) 
lung carcinoma (3), and intestinal carcinoma (2) were obtained at surgery 
or at autopsy. Tissue fragments were embedded in OCT compound (Ames 
Division, Miles Laboratories, Elkhart, IN), snap frozen in liquid nitrogen, 
and stored at -80~  until sectioning. Other fragments were formalin-fixed 
and paraffin-embedded for conventional histology. Cryostat sections were 
fixed in acetone for 10 min at room temperature and were immunostained 
with anti-PECAM-1/CD31 (mAb 9Gll) or mAb 7B4 using avidin-biotin- 
peroxidase complex technique.  Sections were preincubated with normal 
horse serum to prevent nonspecific binding, and then incubated with an op- 
timal dilution of the primary antibody (1/10) for 30 rain. The slides were 
sequentially incubated with biotin-conjugated horse anti-mouse Ig antibod- 
ies followed by avidin-biotin-peroxidase  complex (PR 4002; Vector Labora- 
tories, Burlingame, CA). Each incubation step lasted 30 min with 5-rain 
TBS washes between each step. The sections were finally incubated with 
0.03%  H20~  and 0.06%  3,3' DAB  (Sigma Chemical Co.)  for 3-5  min. 
Slides were then washed for 5 min in running tap water, counterstained with 
hematoxylin for 5 rain, and mounted in Canada balsam. Endogenous perox- 
idase was generally visualized only in eosinophils. 
Measure of EC Barrier Properties 
The Transwell TM cell culture chambers (polycarbonate filters, 0.4 #m pore 
size, Costar, Cambridge, MA) were used as described by Lampugnani et 
al.  (1991).  The polycarbonate filters were coated with  10 /zg/ml  human 
fibronectin for 1 h at room temperature, rinsed with serum-free medium be- 
fore seeding 2  x  104 cells in 100/zl culture medium in the upper compart- 
ment. 600 #l of culture medium filled the lower compartment. Culture was 
continued for 5 d with daily refeeding. Before the experiment, the culture 
medium of both the upper and  lower compartments was replaced with 
medium 199 either serum free or with 5% NCS as indicated in the "Cell 
treatments" paragraph. HRP (0.126/zM; HRP, VI-A type, 44,000 mol wt, 
1,280 U/mg; Sigma Chemical Co.) was added to the upper compartment. 
After 1 h at 37~  the medium in the lower compartment was collected and 
kept on ice until the enzymatic activity of HRP was assayed. To assay HRP 
enzymatic activity (Ortiz de Montellano et al., 1988),  60 #1 of the culture 
medium, collected from the lower compartment, was added to 860 #1 of 
a reaction buffer (50 mM NaH2PO4 with 5 mM guaiacol) and the reaction 
was started by adding 100 #1 H202  (0.6 mM in H20,  freshly made solu- 
tion). The reaction was allowed to proceed for 25 min at room temperature 
before measuring the adsorbance at 470 ran. 
A~inity Chromatography 
Human placentae were minced, lysed with 0.005 % digitonin (Calbiochem, 
San Diego, CA) in TBS with 1 mM Ca  2+,  1 mM Mg  2+ and 1 mM Mn  2+ 
(Ca2+/Mg2+/Mn 2+ TBS),  1 mM PMSF, and 20 U/mi aprotinin for 15 min 
at 4~  followed by 10 min centrifugation at 5,000 g at 4~  Pellets were 
extracted with  1%  Tx-100  (Bio-Rad  Laboratories)  in  Ca2+/Mg2+/Mn 2+ 
TBS,  1 mM PMSF, and 20 U/ml aprotinin for 1 h at 4~  The extract was 
centrifuged for 30 rain at I0,000 g at 4~  The supernatant was stored at 
-70~  before processing. 
mAb 7B4 purified IgGs were covalently coupled to CNBr-Sepharose 
(Pharmacia), according to the manufacturer's instructions. Placenta extract 
was  passed through  a  7B4-CNBr-Sepharose column.  The  column  was 
washed with Ca2+/Mg2+/Mn 2+ TBS and the antigen eluted with 0.1 M ace- 
tic acid, pH 2.5.  Samples were stored at -70~  before further processing. 
Protein Sequencing 
Proteins and peptides were sequenced on a Sequenator (Model 477A;  Ap- 
plied Biosystems) using chemicals and protocols supplied by the manufac- 
turer.  For direct NH2-terminal sequencing, samples of 100-200/zl  were 
dried down on Protein support filters (Porton Instruments) and placed in 
the sequenator reaction cartridge. 
For sequencing of proteins after SDS-PAGE, gels were subjected to over- 
night preelectrophoresis in 0.375  M Tris-HCl, pH 8.8, 0.1% SDS, 20 mM 
mercaptopropionic acid with a current of 5 mA/gel. Samples were boiled 
in sample buffer and subjected to electrophoresis in 25 mM Tris, 0.2 M gly- 
cine, 0.1% SDS, pH 8.3. After SDS-PAGE the proteins were electroblotted 
onto polyvinyl difluoride membranes using 25 mM Tris, 0.2 M glycine, pH 
8.3 as transfer buffer.  The membranes were stained with Coomassie R 250 
in 40% MeOH and destained in 40% MeOH. After extensive washing with 
water individual bands were cut out and subjected to sequencing. 
Peptide Mapping 
Samples were dissolved in 100 ~1 of 0.1 M phosphate buffer,  pH 7.5, con- 
taining  20%  MeOH  and  TPCK-Trypsin  (Worthington)  was  added  (en- 
zyme/substrate ratio 1:100 [wt/wt]). After incubation overnight at 37~  a 
second aliquot of trypsin was added and digestion was continued for 2 h at 
37~  The reaction was terminated by addition of trifluoroacetic acid (TFA) 
to 1% (vol/vol) and samples were chromatographed on a 0.2 cmx  20 cm 
RP-C18 column (5/zm particles) using a model 130 A HPLC system (Ap- 
plied Biosystems) and linear gradient from 0.1% TFA to 70%  CH3CN, 
0.085%  TFA over 50 min (flow:  275/~l/min).  Individual peaks were col- 
lected and subjected to automated sequence analysis as described above. 
Results 
Localization of 7B4 Antigen in Cultured Human 
Endothelial Cells 
Cultured EC monolayers were examined by immunofluores- 
cence microscopy. As reported in Fig. 1 a, mAb 7B4 reacted 
with  an  antigen  concentrated  at  the  boundaries  between 
closely apposed cells. The staining pattern consisted of a thin 
and sharp continuous line highlighting the margins of each 
cell. Notably, a bright signal was detectable in a cell com- 
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distribution  of  7B4  antigen 
and  PECAM-1  in  confluent 
EC stained with mAb 7B4 (a) 
and mAb 9G11 to PECAM-1 
(b).  Immunofluorescence  dis- 
tribution  of  7B4  antigen  in 
colonies  of human epidermal 
keratinocytes that are negative 
to mAb 7B4 (c).  The F-actin 
pattern  of the  same  cells  is 
shown in d. e shows the distri- 
bution  of 7B4 antigen  in im- 
munofluorescence  of noncon- 
fluent  EC.  Cell-free  margins 
are negative  to 7B4  (arrows) 
and  reactivity  is restricted  to 
the  areas  of established  cell 
contacts.  Cells  were  double 
stained for F-actin with F-PHD 
0c). In g the effect of EGTA 
(5 mM for 20 min) on the dis- 
tribution  of  7B4  antigen  in 
confluent  EC  is  shown.  No 
localized  reactivity  could  be 
detected  even at the areas of 
apparent  residual  cell contact 
(arrows).  F-actin  distribution 
in the same ceils  is shown  in 
h. Bars: (a, b, c, d, g, h) 5 #m; 
(e and f) 3 ~zm. 
partment that may be identified with the Golgi area (see also 
Fig.  1,  e  and g).  When confluent monolayers of EC were 
decorated with a  PECAM-1/CD31  mAb a  different pattern 
of staining was observed (Fig.  1 b). The fluorescence signal 
along  cell  margins  was  more  discontinuous  and  in  many 
areas  more diffuse than with mAb 7B4. 
The distribution of mAb 7B4 antigen at cell margins was 
essentially identical when EC were seeded on different sub- 
strata  such as gelatin,  fibronectin,  or vitronectin.  Further, 
staining pattern  and intensity did not change up to  10 cell 
passages  (not shown). 
The presence of 7B4 antigen and, for comparison, that of 
PECAM-1/CD31  in  other  cell  types  including  circulating 
cells (such as platelets,  monocytes and granulocytes), other 
components  of  the  vessel  wall  (such  as  fibroblasts  and 
smooth muscle cells), or keratinocytes was examined by in- 
direct immunofluorescence,  mAb 7B4 recognized only EC 
while it did not bind to any other tested cell type (Table I and, 
e.g.,  Fig.  1, c and d).  In contrast, as expected (Newman et 
al.,  1990), PECAM-1 was detected in monocytes, polymor- 
phonuclear  cells  and  platelets  (Table  I).  The  reactivity  of 
7B4 was restricted to human EC; bovine EC from both large 
vessels and capillaries  were negative (not shown).  The en- 
richment of 7B4 at cell borders requires  the establishment 
of intercellular contacts. In nonconfluent cultured EC exam- 
ined  by  indirect  immunofluorescence  the  antigen  was  de- 
tected only at contacting cell borders and never along free 
cell edges (Fig.  1, e and f).  In nonconfluent EC the level of 
the antigen  exposed at the cell  surface was comparable to 
that  of confluent  cells.  Indeed,  mAb 7B4 immunoprecipi- 
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Antibodies  Antibodies 
7B4  PECAM- 1 
Endothelial cells  +  + 
Platelets  -  + 
Monocytes  -  + 
Granulocytes  -  + 
Keratinocytes  -  - 
Fibroblast  -  - 
Smooth  muscle cells  -  - 
Reactivity of human cultured cells and human blood cells to 7B4 and anti- 
PECAM-1  was tested by indirect immunofluorescence. 
tated comparable amounts of ~25Iodine-labeled protein from 
the same number of either confluent or nonconfluent EC (not 
shown). The maintenance of  7B4 antigen at the cell-cell con- 
tacts depends on the presence of Ca  2§  EGTA (5 mM for 20 
min) induced the disappearance of the antigen from the cell 
boundaries even in the areas of apparent residual intercellu- 
lar contacts (Fig.  1, g and h). This effect was accompanied 
by increased permeability of the EC monolayer (see Table 
HI).  The amount of 125Iodine-labeled protein immunopre- 
cipitated by mAb 7B4 was comparable in EGTA-treated and 
in control cells (see also Fig.  4),  thus indicating that the 
treatment induces a redistribution of the protein on the cell 
membrane but not its disappearance. 
Expression of 7B4 Antigen In Situ 
Expression of 7B4 antigen in situ was studied in a series of 
tissues,  as  listed  in  Table  II.  For  comparison,  the  im- 
munolocalization of PECAM-1/CD31  was  also  examined. 
The 7B4 antigen and PECAM-1 showed a different cellular 
distribution in tissue sections. Immunoreactivity to 7B4 was 
restricted to the vascular endothelial layer of the vessels in 
all the tissues examined, which comprised both normal and 
malignant  tissues.  The  molecule  was  constitutively  ex- 
pressed in the endothelium of muscular arteries, arterioles, 
capillaries, venules, and veins and was mostly present at EC 
boundaries as shown in Fig. 2 (a and c). No significant stain- 
ing was observed on the apical or basal aspect of EC mem- 
brane or in the cytoplasm. Cardiac and skeletal muscle, vas- 
cular  smooth  muscle,  macrophages,  fibroblasts,  and  any 
tested epithelial type did not contain detectable levels of this 
antigen. The immunostaining for PECAM-1/CD31 was dif- 
ferent from that of 7B4 both in terms of tissue specificity 
and cellular localization. In fact, PECAM-1/CD31 was pres- 
ent also in nonendothelial cells, including platelets, mega- 
karyocytes, and macrophages. In addition, the staining for 
PECAM-1/CD31 in EC lined intercellular contact rims and 
was also diffuse in the cytoplasm (Fig. 2 b). Interestingly, the 
pattern of cellular localization of 7B4 and PECAM-1/CD31 
in tissue sections was similar to that observed in cultured EC 
(compare Fig.  1, a  and b). 
Biochemical Characterization of 7B4 Antigen 
To identify the antigen recognized by mAb 7B4,  extracts 
from [35S]methionine-labeled EC were immunoprecipitated 
with the mAb. As shown in Fig. 3 (A), mAb 7B4 precipitated 
a major protein band of ~140 kD apparent molecular mass. 
As a control an isotype matched mAb to CD2 lymphocyte 
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Cryostat sections of skin, kidney, heart, lung, thymus, lymph node, thyroid, 
parathyroid, salivary gland, stomach, ileum, colon, testis, placenta, bone mar- 
row,  lung squamous  carcinoma,  and colon adenocarcinoma were  immuno- 
stained with mAb  7B4  and  mAb  9Gll  to  PECAM-1  using avidin-biotin- 
peroxidase method. 
* The antigen was constitutively expressed by EC in all tissues examined. The 
reactivity was present in muscular arteries, arterioles, capillaries, venules, and 
veins. 
* The reactivity was expressed by macrophages lining lymph node  sinuses. 
These cells represent a peculiar subset of macrophages sharing many features 
with EC. 
antigen, which is not expressed by EC, was used in all the 
immunoprecipitation experiments (Fig. 3). These data indi- 
cate that 7B4 recognizes a protein synthesized by EC. 
mAb 7B4 immunoprecipitated a  major band of 140 kD 
also from 125Iodine-surface labeled EC (Fig. 3 B), indicat- 
ing that the antigen is externally exposed. After reduction 
with 2-mercaptoethanol, the apparent molecular mass  in- 
creased slightly to 145 kD  (Fig.  3 B),  suggesting that in- 
trachain disulfide bonds are present in the molecule. 
Neuraminidase treatment (2 U/ml for 45 min) resulted in 
a decrease to 135 kD of the apparent molecular mass (Fig. 
3 C), suggesting sialylation of the protein. Furthermore, the 
protein recognized by 7B4 bound to Con A, but not to WGA 
(Fig. 3 D) suggesting that it is a glycoprotein with mannose- 
containing oligosaccharide moieties. 
EDTA (50/~M for 15 min at 37~  Miiller et al.,  1989) 
did not strip 7B4 antigen from EC surface (data not shown), 
thus, indicating that it is an integral membrane protein. In 
apparent  contrast,  when  125Iodine-labeled  EC  were  ex- 
tracted with TX-114 detergent the 7B4 antigen was mostly 
immunoprecipitated from the buffer phase (Fig. 4 A). This 
Lampugnani et al. A  Protein  of Endothelial Intercellular  Junctions  1515 Figure 2.  Immunoperoxidase localization of 7134 antigen and 
PECAM-1. Cryostat sections of a human lymph node were stained 
with mAb 7B4 (a) and mAb to PECAM-1 (b). (a) Reactivity to 
mAb 7B4 is selectively  expressed by EC lining an arteriole, a ven- 
ule (lower  left), and some cross-sectioned capillaries. The staining 
is present at lateral cell borders of contiguous EC. (b) PECAM-1 
reactivity is expressed by EC lining two venules and some macro- 
phages of the connective tissue (upper left). The staining of EC is 
weak in the cytoplasm and more pronounced at the intercellular 
borders. (c) Immunoperoxidase localization of 7134 antigen in a 
cryostat section of a human skeletal muscle. An interstitial capil- 
lary vessel is highlighted  by the linear staining of  EC with mAb 7B4 
(arrows). No reactivity is present on the striated muscle cells. 
Avidin-biotin-peroxidase  complex, counterstained with hematoxy- 
lin. Bars: (a) 40/~m; (b and c) 25/zm. 
unexpected distribution has been reported for other integral 
membrane proteins (Volk and Geiger,  1986 and references 
therein). 
7B4 was sensitive to trypsin (0.01% for 20 rain) both in the 
absence and presence of Ca  2+ (Fig. 4 A). 
PI-specific PLC did not detach 7B4 from the cell surface 
(Fig. 4 A).  This makes unlikely a connection through PI- 
containing lipids as reported for other membrane proteins 
(Ferguson and Williams, 1988). 
100-kD band(s) appeared constantly in the immunopre- 
cipitate from 12qodine surface-labeled EC at variable inten- 
sity and was found occasionally in [3sS]methionine-labeled 
EC. Surface iodination requires longer cell manipulation be- 
fore extraction than [35S]methionine metabolic labeling (see 
Materials and Methods).  In preliminary experiments,  we 
found that the intensity of this band increased in parallel to 
a  decrease of the  140-kD  band when the cell extract was 
repeatedly frozen and thawed. We then suggest that the 100- 
kD band represents a degradation product of the higher 140- 
kD band. An unspecific band of •180  kD appeared in the 
immunoprecipitates  from  12qodine-surface  labeled EC  of 
both CD2 and 7B4.  This protein had an immunoglobulin- 
like behaviour as it linked to protein G-Sepharose in the 
absence of CD2 or 7B4 (not shown) and its molecular mass 
decreased to ,~55 kD upon reduction (Fig. 3 B). Immuno- 
precipitates of cell extracts precleared on protein G  were 
depleted of this unspecific band (Fig. 4, A and B). It is not 
a metabolic product of the cells, as it never appeared in im- 
munoprecipitates from [3~S]methionine-labeled  EC.  Over- 
all, this strongly suggests that it represents serum derived 
IgG absorbed to EC from the culture medium. 
Comparison of 7B4 to Other EC Adhesion Proteins 
Intercellular location and size suggest that 7B4 antigen could 
be similar to other molecules previously found at intercellu- 
lar EC contacts. By immunoprecipitafion  analysis, PECAM- 
1/CD31 migrates at a lower position than 7B4 antigen (Fig. 
4 B). Furthermore, while 7B4 is sensitive to trypsin treat- 
ment (Fig.  4  A),  PECAM-1/CD31  was detached in tryp- 
sinized cells (not shown). These data and the differences in 
cell recognition specificity (Tables I and II) indicate that 7B4 
is  a  protein  distinct from PECAM-1/CD31.  Furthermore, 
transfected COS  cells  expressing  a  full-length PECAM-1 
molecule are not recognized by mAb 7B4 (R. Pigott, unpub- 
lished results). 
EC reportedly express mRNA for membrane proteins of 
the intercellular contacts belonging to the cadherin family: 
N  and P  (Liaw et al.,  1990).  Cadherins have a molecular 
weight in the range of that of 7B4 antigen.  We therefore 
tested  whether  the  7B4  antigen could be  recognized by 
cadherin antibodies. A polyclonal antibody directed to the 
COOH-terrnlna124 amino acid domain of cadherins (Geiger 
et al., 1990) was used. The conserved nature of this domain 
allows this antibody to react with all known cadherins. This 
antibody detected a band at the expected 140 kD apparent 
molecular mass in the total EC extracts  (Fig.  5  A),  thus 
confirming the presence of cadherins in human EC. It also 
recognized a band of slightly lower molecular mass in the 
immunoprecipitate of mAb 7B4. As expected, no reactivity 
was found in the immunoprecipitate of anti-PECAMA (Fig. 
5  A).  When polyclonal antibodies to N-  and P-cadherins 
The Journal  of Cell Biology,  Volume 118, 1992  1516 Figure 3. (A) Immunoprecipitation analysis of [35S]methionine-labeted  confluent EC. mAb 7B4 immunoprecipitated a band of ,~140 kD 
apparent MW (arrow). The isotype matched mAb to the lymphocytic CD2 antigen, not expressed by EC, was used as a negative control. 
(B) Immunoprecipitation analysis of z25Iodine-surface  labeled confluent EC. The effect of reduction on 7B4 antigen migration position 
(arrows) is shown. (C) The effect of treating the labeled EC monolayer with neuraminidase (2 U/ml for 45 min) before extraction and 
immunoprecipitation with mAb 7B4 (arrows) is shown. D illustrates the binding of 7134 antigen to lectin-conjugated resins. 7B4 antigen 
(arrows) could be immunoprecipitated from the eluant of ConA-Sepharose obtained washing the resin with the competing sugar methyl 
c~-o-mannopyranoside.  When the cell extract was made to react with Con A in the presence of  methyl c~-o-mannopyranoside  no 7B4 antigen 
could be immunoprecipitated from the eluant obtained washing the resin with the competing sugar methyl c~-a-mannopiranoside. Under 
the same condition, as expected, the antigen could be immunoprecipitated from the unbound fraction (supernatant). 7B4 antigen (arrows) 
could  not  be immunoprecipitated  from the  eluant  of WGA-agarose obtained  washing the  resin with  the  competing  sugar n-aeetyl- 
glucosamine. 7B4 antigen was present, as expected, in the unbound fraction supernatant. The migration of molecular weight standards 
run in parallel is shown on the right of each panel. 
were used in the same kind of experiments they recognized 
a protein band of ~140 kD in the total cell extract (Fig. 5 
B).  The  band  recognized  by  anti-P-cadherin  was  much 
fainter than that recognized by anti-N-cadherin, in apparent 
agreement with Liaw et al. (1990). None of the two antibod- 
ies detected any specific band in the immunoprecipitate of 
mAb 7B4 (Fig. 5 B) thus indicating that 7B4 antigen does 
not correspond to N- or P-cadherins. The high MW bands 
detected in both the 7B4 and PECAM-1 antibodies immuno- 
precipitates are the IgG recognized by iodinated protein A 
(Fig. 5, A and B). Both a monoclonal and a polyclonal anti- 
body to bovine endothelial cell V-cadherin (Heimark et al., 
1990) did not recognize any specific band in cultured human 
umbilical vein EC, possibly indicating a lack of crossreac- 
tivity. 
Identification of 7134 Antigen as a Novel Cadherin by 
Amino Acid Sequencing 
Preparations  of 7B4  antigen  purified  by  immunoaflinity 
columns from placenta tissue were subjected to automated 
NH2-terminal microsequencing yielding information up to 
residue  17  (Fig.  6).  The  7B4  antigen  NH2-terminal  se- 
quence  showed  identity  with  the  cDNA  deduced  NH2- 
terminal sequence of a new member of the cadherin family 
recently  characterized  at  the  cDNA  level  and  denoted 
cadherin-5 (Suzuki et al.,  1991) (Fig. 6).  Tryptic mapping 
of the protein and sequencing of the resulting peptides indi- 
cated identity also in some internal sequences (Fig. 6). 
Effect of mAb 7B4 on Endothelial Cell 
Barrier Function 
The intercellular location of 7B4 suggests that it can play a 
role in the functional organization of endothelial cell to cell 
junctions. When mAb 7B4 either in the form of intact IgG 
(up to 400/~g/rnl) or Fab fragments (up to 400 #g/ml) were 
added to EC monolayers up to 12 h,  they had no apparent 
effect  on cell morphology as examined by phase-contrast mi- 
croscopy and  immunofluorescence by  actin  staining  (not 
shown). To increase our sensitivity, we then used a perme- 
ability assay, which had been previously found to show varia- 
Lampugnani et al, A  Protein of Endothelial Intercellular Junctions  1517 Figure 4.  Immunoprecipitation  analysis  of 125Iodine-surface la- 
beled EC. (A) The effect of various treatments on 7134 antigen is 
shown: partition  of 7B4 antigen in TX-114 buffer and detergent 
phase; EC treatment with trypsin (0.01% for 20 min) in the presence 
of either  1 mM Ca  2§ or 1 mM EGTA and for comparison  1 mM 
EGTA alone or 1 mM Ca  2+ and Mg2+; and EC treatment with PI- 
PLC (2 #g/ml for 20 rain). (B) Comparison of the immunoprecipi- 
tation patterns obtained with mAb 71M and mAb to PECAM-1. In 
these experiments cell extracts were precleared  by incubation for 
1 h with uncoupled protein G Sepharose before immunoprecipita- 
tion. The migration of molecular weight markers run in parallel is 
shown on the right of each panel. 
tions of the barrier function of EC  even in the absence of 
overt morphological alterations (Lampugnani et al.,  1991). 
When Fab fragments were added to EC grown on Transwell 
filters a dose-response increase in the permeability of the EC 
monolayer was observed (Fig. 7). This increase was apparent 
at "0100 gg/ml mAb and at a minimal time of incubation of 
2  h  reaching a  plateau between 4  and 6  h  (not shown). 
Comparable results were also obtained with intact IgGs. 
7B4 Antigen Organization  in 
Endothelial Cells Treated with Agents That Alter 
Monolayer Integrity 
Several molecules have been reported to alter morphology 
and intercellular contacts of EC.  As reported in Table HI, 
treatment  of EC  with  TNF  and  7IFN,  with  thrombin  or 
elastase significantly increased  monolayer permeability in 
TransweU experiments. 
We  checked  first  by  indirect  immunofluorescence  the 
effect of these treatments on the distribution of 7B4 antigen. 
Thrombin added to the cells (5  U/ml for 30 min) induced 
retraction accompanied by small areas of detachment at in- 
tercellular boundaries (see actin, Fig. 8 c). 7B4 antigen dis- 
Figure 5. Immunoblot analysis with pan-cadherin,  P-cadherin, and 
N-cadherin  antibodies of mAb 7B4 and anti-PECAM-1 immuno- 
precipitates. (A) Cell extracts of  confluent EC were immunoprecip- 
itated with mAb 7134 or anti-PECAM-1 (see Materials and Meth- 
ods). The immunoprecipitates were blotted with anti-pan-cadherin. 
For comparison the starting cell extract (total cell extract) was blot- 
ted in parallel.  (B) cell extracts of confluent EC were immunopre- 
cipitated  with mAb 7B4 or anti-PECAM-1. The immunoprecipi- 
tates  and,  for comparison,  the  starting  cell  extracts  (total  cell 
extract)  were  blotted  with  anti-P-cadherin  and  anti-N-cadherin. 
The migration of molecular weight markers is shown on the right 
of each panel. 
appeared from areas of cell retraction and the staining was 
restricted  to  residual  cell  contacts  (Fig.  8  d,  arrows). 
Changes in 7134 antigen distribution was even more dramatic 
after elastase treatment of the cells (0.8 #M for 30 min) (Fig. 
8f). Cell retraction was observed after treatment (see actin, 
Fig. 8 e), yet 7B4 antigen did not show any discrete distribu- 
tion even at residual intercellular contacts, but was diffusely 
distributed  on  EC  membrane.  Interestingly,  the  effect of 
thrombin on cell retraction and 7B4 localization was fully re- 
versible in  ~ol  h,  even in  the  continuous  presence of the 
stimulus. In contrast the effect of elastase was not reversible 
up to 3-4 h  (not shown). 
When EC were incubated with 7IFN and TNF (200 U/ml 
and 100 U/ml for 72 H) they acquired elongated morphology 
with relaxed intercellular  contacts (Fig.  8 g)  as described 
(Stolpen et al., 1986). 7B4 assumed a peculiar, punctate dis- 
tribution all over the cell body and could be found at cell to 
cell contacts only in a  few areas (Fig.  8 h). 
We then  investigated whether  the  morphological effects 
observed  after  EC  treatment  with  thrombin,  elastase  or 
3,IFN and TNF were paralleled by quantitative or qualitative 
modification  of 7B4  antigen.  As  reported  in  Fig.  9,  the 
amount  of  125Iodine-labeled  antigen  precipitable  by  mAb 
7B4 was unmodified after 7IFN and TNF (Fig. 9 B and par- 
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Figure 6.  Comparison of the 
7B4  NH2-terminal  sequence 
and sequences  obtained from 
tryptic peptide mapping (up- 
per lanes) with the eDNA de- 
rived sequence of human cad- 
herin-5  (lower lanes;  Suzuki 
et al., 1991). Sure residues are 
shown by capital letters  and 
<  100% sure residues  are in- 
dicated  by  lower  letters.  A 
"-" indicates  that no residue 
was identified.  The predicted 
proteolytic processing site  of 
the precursor is indicated with 
an arrow. (N) Potential aspara- 
gine glycosylation sites.  The 
putative transmembrane region 
is underlined. 
tiaUy reduced after thrombin or elastase  (30 and 40%,  re- 
spectively; Fig. 9  A). 
Discussion 
In this paper we describe several biological and biochemical 
characteristics  of a  novel, endothelial-specific cadherin. 
This protein was identified adopting the indirect approach 
of developing mouse mAbs to human EC and selecting one 
mAb, denoted 7B4, on the basis of its ability to stain inter- 
cellular boundaries in indirect immunofluorescence. 
mAb 7134 stains EC both in vitro and in situ. In tissue sec- 
tions it stains only the endothelium of blood vessels of differ- 




Figure 7.  Effect of mAb 7B4 
on the permeation through EC 
monolayer of HRE  EC were 
grown to confluency on Tras- 
well  filters.  The  EC  mono- 
layer was  incubated  for 6  h 
with  the  indicated  doses  of 
7B4  Fab  fragments  and  the 
~oo  2oo  400  7~ ~,9:m)  passage of HRP through the 
endothelial  layer  was  mea- 
sured during the last hour. The ordinate is the percentage increase 
over control of the OD at 470 nm. Control EC were treated  with 
Fab (400 #g/ml) from nonimmune mouse IgG. Control value was 
235  •  30 x  10  -30D at 470 nm. The mean value of triplicate  de- 
terminations  +  SD in a representative  experiment out of six per- 
formed are shown. 
sues and it does not recognize circulating blood cells, such 
as monocytes, polymorphonuclear cells, and platelets.  Fur- 
thermore, mAb 7B4 does not react with any other tested cul- 
tured cell types (including human fibroblasts, smooth muscle 
cells and keratinocytes). 
The issue that 7B4 antigen is a component of intercellular 
junctions is supported by its exclusive immunocytochemical 
localization in situ and in vitro. The fluorescence pattern ob- 
served in cultured EC closely resembles that observed by im- 
munohistochemistry  in  different vessels  in  situ.  In either 
condition, mAb 7B4 identifies a fine, continuous line along 
Table IlL Permeation of HRP Across Transwell Filters 
OD  X 10  -3 
Endothelial cells 
Control  483  •  6 
7IFN and TNF  1,167 •  130 
Thrombin 
20 U/nil  1,165  +  191 
5 U/ml  874 •  63 
Elastase 
0.6 #M  1,415 •  291 
0.3 ~M  722  +  38 
-EGTA  856 •  36 
Empty filter  1,334 •  103 
EC were grown to confluency on Transwell filters and treated with the indicat- 
ed doses of thrombin, elastase or EGTA (5 raM) for 30 rain. 7IFN and TNF 
(200 and 100 U/ml, respectively) were given to the cells for 72 h. Permeation 
of HRP,  measured as described in Materials and Methods,  was quantified as 
OD at 470 nM.  Mean of triplicate determinations  :t:  SD. 
Lamptlgnani et al. A Protein of Endothelial Intercellular Junctions  1519 Figure 8. Immunofluorescence 
of  cultured EC after treatments 
affecting cell to cell contacts. 
The cells were double stained 
with  mAb  7B4  followed by 
rhodaminated secondary anti- 
body to mouse immunoglobu- 
tins (b, d, f, h) and for F-actin 
with F-PHD (a, c, e, g). (a and 
b) Control. (c and d) Throm- 
bin  (5  U/ml for 30 min).  (e 
and  f) Elastase (0.8 #M for 30 
min). (g and h) 7IFN and TNF 
(200  U/ml  and  100  U/ml, 
respectively, for 72  h).  Ar- 
rows in  d  indicate  residual 
areas of cell to cell contacts 
stained by mAb 7B4. Arrows 
in h point to 7B4 positive dots 
scattered within the cell body. 
Bar, 5 #m. 
the rim of intercellular boundaries. In cultured EC, periph- 
eral staining is observed exclusively at contact rims, while 
contact-free segments of the cell membrane are negative in 
subconfluent cultures. A constant feature of 7134 antigen is 
its abundant intracellular storage in vitro, presumably in a 
Golgi-like vesicular compartment. 
Data of 7B4 distribution are consistent with a role of 7B4 
antigen in regulating EC cell-cell adhesion structures. Addi- 
tional functional data supports this hypothesis. First, mAb 
7B4 increases the permeability of EC cultured or Transwell 
filters by ,-o40% over the control value. Second, comparing 
confluent vs subconfluent cells,  the antigen is localized at 
cell boundaries only where cells come in touch. Third, 7B4 
topography  is  markedly  modified by  treatments  such  as 
-yIFN and TNF, thrombin and elastase that increase EC per- 
meability. 
Interestingly, in cells treated with thrombin and elastase, 
7B4 disappearance at cell boundaries is accompanied by a 
moderate decrease in the amount of antigen expressed by the 
cells. In contrast, in sparse cells or in ceils treated with 7IFN 
and TNF the changes in 7B4 distribution do not correspond 
to detectable changes in 7B4 qualitative or quantitative ex- 
pression. This suggests that 7]34 organization in intercellular 
junctions could be regulated not only by direct digestion/de 
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affecting EC cell to cell contacts 
on the level of the externally ex- 
posed 7B4 antigen. (.4) Confluent 
EC  were surface labeled  with 
125Iodine then treated with elastase 
(0.8 #M for 30 rain) or thrombin 
(5  U/ml for 30 rain) before ex- 
traction  and  immunoprecipita- 
tion with mAb 7B4. (B) EC were 
grown for 72 h in the presence of 
3,IFN and  TNF  (200 and  100 
U/ml,  respectively) before sur- 
face labeling with  12~Iodine and 
immunoprecipitation. Molecular 
weight markers are shown on the 
right of each panel. 
novo exposure of the antigen but also by antigen disassem- 
bling and relocation within the cell membrane. 
The 7B4 antigen has been characterized for several bio- 
chemical properties. First, by lactoperoxidase-catalyzed io- 
dination it appears to be externally exposed and EDTA treat- 
ment  supports  its  firm association with the phospholipid 
bilayer (Mfiller et al.,  1989).  Further, it is produced by EC 
since it can be immtmoprecipitated from metabolically la- 
beled cell extracts. A second prominent biochemical prop- 
erty is its content of  mannose and sialic acid oligosaccharide 
moieties witnessing its glycoprotein nature.  The apparent 
molecular mass of the 7B4 antigen is 140 kD. An additional 
band or group of bands of "o100 kD is occasionally precipi- 
tated from metabolically labeled and constantly precipitated 
from  surface-labeled  EC  extracts.  Since  its  intensity in- 
creases in parallel to a decrease of the 140-kD band in sev- 
eral  experimental  tests,  including  repeated  freezing  and 
thawing cycles, it is likely that it represents a degradation 
product of the higher MW protein. 
Many characteristics of 7B4 are in common with some 
members of the cadherin family. These include (a) sensitiv- 
ity to trypsin digestion (Albelda, 1990);  (b) partition in TX- 
114 buffer phase (Volk and Geiger,  1986);  (c)  binding to 
ConA (Damsky et al., 1983; Volk and Geiger, 1986); (d) re- 
quirement of Ca  2+ for the localization of the antigen at the 
cell contacts (Volk and Geiger, 1986; Vestweber et al., 1985; 
Takeichi, 1990).  In addition, 7B4 antigen is recognized by 
a  polyclonal antibody directed  to  the conserved  COOH- 
terminal cytoplasmic domain of all known cadherins. 
The NH2-terminal sequence data and sequence data from 
tryptic peptide  mapping  confirmed that 7B4  is  indeed a 
member of the cadherin family. The sequences essentially 
showed identity with the cDNA deduced sequence of a new 
member of the cadherin family recently characterized and 
denoted as cadherin-5 (Suzuki et al.,  1991). This molecule 
was identified in human placenta cDNA by the aid of poly- 
merase  chain  reaction  using  degenerated  primers  corre- 
sponding to highly conserved amino acid sequences from the 
cadherin cytoplasmic domain. The entire putative coding se- 
quence of cadherin-5 has been reported (Suzuki et al., 1991) 
and exhibits significant homology with those of the previ- 
ously described cadherin sequences and the overall molecu- 
lar structure is essentially the same as that of the other cad- 
herins.  Data  reported  here  confirm  the  existence  of  a 
cadherin-5 protein and characterize its biochemical and bio- 
logical behaviour. The specific localization of this protein in 
endothelial cells distinguishes this cadherin from the other 
members  of the  family that  present  a  quite  widespread 
distribution.  This molecule appears to be a  candidate not 
only as a specific marker for endothelial cell junctions but 
also as a  potential regulator of endothelial continuity re- 
quired for the maintenance of permeability control and the 
antithrombotic properties of the endothelium. 
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